Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies

BACKGROUND: The visual pathways are increasingly recognized as an ideal model to study neurodegeneration in multiple sclerosis (MS). Low-contrast letter acuity (LCLA) and optical coherence tomography (OCT) are validated measures of function and structure in MS. In fact, LCLA was the topic of a recen...

Full description

Saved in:
Bibliographic Details
Published in:J Neuroophthalmol
Main Authors: Nolan, Rachel C., Akhand, Omar, Rizzo, John-Ross, Galetta, Steven L., Balcer, Laura J.
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026328/
https://ncbi.nlm.nih.gov/pubmed/29750734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNO.0000000000000662
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items